Activest Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Hold
166
– – ﹤0.01% 581
2026
Q2
$9.5K Sell
166
-299
-64% -$16.4K ﹤0.01% 591
2026
Q1
$26.3K Buy
465
+27
+6% +$1.57K ﹤0.01% 458
2025
Q4
$26K Buy
+438
New +$23.8K ﹤0.01% 443
2023
Q1
– Sell
-2,141
Closed -$181K – 343
2022
Q4
$181K Hold
2,141
– – 0.05% 92
2022
Q3
$181K Buy
+2,141
New +$191K 0.06% 92

Other funds holding BMRN

Activest Wealth Management's BMRN Position: Q3 2026 in Review

Activest Wealth Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 166 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Activest Wealth Management first reported a position in BMRN in Q3 2022 and has held it in 6 quarters since. The position peaked at $181K in Q3 2022. 565 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Activest Wealth Management held 166 shares of BioMarin Pharmaceuticals worth $10K as of Q3 2026.
  • Activest Wealth Management left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #581 holding.
  • Activest Wealth Management first reported a position in BioMarin Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
  • Activest Wealth Management's BioMarin Pharmaceuticals position peaked at $181K in Q3 2022.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.